Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

The prodrome and clinical risk for psychotic disorders.

Goulding SM, Holtzman CW, Trotman HD, Ryan AT, Macdonald AN, Shapiro DI, Brasfield JL, Walker EF.

Child Adolesc Psychiatr Clin N Am. 2013 Oct;22(4):557-67. doi: 10.1016/j.chc.2013.04.002. Review.

2.

Predicting psychosis in a general adolescent psychiatric sample.

Lindgren M, Manninen M, Kalska H, Mustonen U, Laajasalo T, Moilanen K, Huttunen M, Cannon TD, Suvisaari J, Therman S.

Schizophr Res. 2014 Sep;158(1-3):1-6. doi: 10.1016/j.schres.2014.06.028.

PMID:
25015028
3.

Affect recognition in people at clinical high risk of psychosis.

Addington J, Piskulic D, Perkins D, Woods SW, Liu L, Penn DL.

Schizophr Res. 2012 Sep;140(1-3):87-92. doi: 10.1016/j.schres.2012.06.012.

4.

Psychosis-like experiences and distress among adolescents using mental health services.

Kline E, Thompson E, Bussell K, Pitts SC, Reeves G, Schiffman J.

Schizophr Res. 2014 Feb;152(2-3):498-502. doi: 10.1016/j.schres.2013.12.012.

PMID:
24411529
5.

Prodromal psychosis detection in a counseling center population in China: an epidemiological and clinical study.

Zhang T, Li H, Woodberry KA, Seidman LJ, Zheng L, Li H, Zhao S, Tang Y, Guo Q, Lu X, Zhuo K, Qian Z, Chow A, Li C, Jiang K, Xiao Z, Wang J.

Schizophr Res. 2014 Feb;152(2-3):391-9. doi: 10.1016/j.schres.2013.11.039.

6.

Sexual dimorphisms and prediction of conversion in the NAPLS psychosis prodrome.

Walder DJ, Holtzman CW, Addington J, Cadenhead K, Tsuang M, Cornblatt B, Cannon TD, McGlashan TH, Woods SW, Perkins DO, Seidman LJ, Heinssen R, Walker EF.

Schizophr Res. 2013 Mar;144(1-3):43-50. doi: 10.1016/j.schres.2012.11.039.

7.

Substance use in individuals at clinical high risk of psychosis.

Buchy L, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Heinssen R, Bearden CE, Mathalon D, Addington J.

Psychol Med. 2015 Aug;45(11):2275-84. doi: 10.1017/S0033291715000227.

PMID:
25727300
8.

Altered relationships between age and functional brain activation in adolescents at clinical high risk for psychosis.

Karlsgodt KH, van Erp TG, Bearden CE, Cannon TD.

Psychiatry Res. 2014 Jan 30;221(1):21-9. doi: 10.1016/j.pscychresns.2013.08.004.

9.

Negative symptoms and impaired social functioning predict later psychosis in Latino youth at clinical high risk in the North American prodromal longitudinal studies consortium.

Alderman T, Addington J, Bearden C, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Cadenhead KS.

Early Interv Psychiatry. 2015 Dec;9(6):467-75. doi: 10.1111/eip.12128.

10.

Duration of unspecific prodromal and clinical high risk states, and early help-seeking in first-admission psychosis patients.

Schultze-Lutter F, Rahman J, Ruhrmann S, Michel C, Schimmelmann BG, Maier W, Klosterk├Âtter J.

Soc Psychiatry Psychiatr Epidemiol. 2015 Dec;50(12):1831-41. doi: 10.1007/s00127-015-1093-3.

PMID:
26155901
11.

Should a "Risk Syndrome for Psychosis" be included in the DSMV?

Yung AR, Nelson B, Thompson AD, Wood SJ.

Schizophr Res. 2010 Jul;120(1-3):7-15. doi: 10.1016/j.schres.2010.03.017.

PMID:
20382506
12.

Emotional and behavioral symptomatology reported by help-seeking youth at clinical high-risk for psychosis.

Thompson E, Kline E, Ellman LM, Mittal V, Reeves GM, Schiffman J.

Schizophr Res. 2015 Mar;162(1-3):79-85. doi: 10.1016/j.schres.2015.01.023.

PMID:
25638728
13.

North American Prodrome Longitudinal Study (NAPLS 2): The Prodromal Symptoms.

Addington J, Liu L, Buchy L, Cadenhead KS, Cannon TD, Cornblatt BA, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon DH, McGlashan TH.

J Nerv Ment Dis. 2015 May;203(5):328-35. doi: 10.1097/NMD.0000000000000290.

14.

Movement abnormalities predict transitioning to psychosis in individuals at clinical high risk for psychosis.

Callaway DA, Perkins DO, Woods SW, Liu L, Addington J.

Schizophr Res. 2014 Nov;159(2-3):263-6. doi: 10.1016/j.schres.2014.09.031.

15.

Predictors of a clinical high risk status among individuals with a family history of psychosis.

Stowkowy J, Addington J.

Schizophr Res. 2013 Jul;147(2-3):281-6. doi: 10.1016/j.schres.2013.03.030.

16.

Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group.

Yung AR, Phillips LJ, Yuen HP, Francey SM, McFarlane CA, Hallgren M, McGorry PD.

Schizophr Res. 2003 Mar 1;60(1):21-32.

PMID:
12505135
17.

Specificity of Incident Diagnostic Outcomes in Patients at Clinical High Risk for Psychosis.

Webb JR, Addington J, Perkins DO, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Heinssen RK, Seidman LJ, Tarbox SI, Tsuang MT, Walker EF, McGlashan TH, Woods SW.

Schizophr Bull. 2015 Sep;41(5):1066-75. doi: 10.1093/schbul/sbv091.

18.

White matter microstructure in individuals at clinical high risk of psychosis: a whole-brain diffusion tensor imaging study.

von Hohenberg CC, Pasternak O, Kubicki M, Ballinger T, Vu MA, Swisher T, Green K, Giwerc M, Dahlben B, Goldstein JM, Woo TU, Petryshen TL, Mesholam-Gately RI, Woodberry KA, Thermenos HW, Mulert C, McCarley RW, Seidman LJ, Shenton ME.

Schizophr Bull. 2014 Jul;40(4):895-903. doi: 10.1093/schbul/sbt079.

19.

Neurocognitive function as a possible marker for remission from clinical high risk for psychosis.

Lee TY, Shin YS, Shin NY, Kim SN, Jang JH, Kang DH, Kwon JS.

Schizophr Res. 2014 Mar;153(1-3):48-53. doi: 10.1016/j.schres.2014.01.018.

PMID:
24529365
20.

The relationship between psychotic-like symptoms and neurocognitive performance in a general adolescent psychiatric sample.

Lindgren M, Manninen M, Laajasalo T, Mustonen U, Kalska H, Suvisaari J, Moilanen K, Cannon TD, Huttunen M, Therman S.

Schizophr Res. 2010 Oct;123(1):77-85. doi: 10.1016/j.schres.2010.07.025.

PMID:
20729039
Items per page

Supplemental Content

Support Center